|
|||
2017-02-24 13:50:00 CET 2017-02-24 13:50:00 CET Biohit Oyj - Managers' transactionsBiohit Oyj - Managers' TransactionsBiohit Oyj - Managers' Transactions, February 24, 2017 at 2:50 pm local time (EET) Person subject to the notification requirement Name: Nordström, Niklas Position: Chief Financial Officer -------------------------------------------------------------------------------- Initial Notification Reference number: 74370089ATTSNBXJVT29_20170224110621_9 -------------------------------------------------------------------------------- Issuer Name: Biohit Oyj LEI: 74370089ATTSNBXJVT29 -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-23 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Subscription Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 2303 Unit price: 2,27660 Euro Aggregated transactions Volume: 2303 Volume weighted average price: 2.27660 Euro Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com |
|||
|